Back to Stakeholders

Insel Gruppe AG operates Inselspital (Bern University Hospital), one of Switzerland's five dedicated centers for psychedelic medicine research and among the largest university hospital groups in Europe. The hospital's psychiatry department runs the HaD-PET neuroimaging study on harmine and DMT, and has published real-world outcomes of LSD- and psilocybin-assisted psychotherapy in routine clinical care.

Academic Research

0 papers

Published Papers

0

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Unknown

Clinical Care Delivery Snapshot

Health Systems & Hospitals

Provider Model

Health System / Hospital Program

Organization Status

Unknown

Psychedelic Services

Unknown

Service Coverage

Global

Service Profile

Care Settings

Hospital Outpatient

Payer Models

Unknown

Non-Psychedelic Service Mix

Unknown

Visit Provider

Care Delivery Notes

Backfilled profile for existing L2 clinical care delivery stakeholder.

Quick Facts

Type
Other
HQ
Inselspital, University Hospital Bern, Switzerland
Website
Visit

Sponsored Trials

1